Literature DB >> 2941045

Induction of tolerance to a murine fibrosarcoma in two zones of dosage--the involvement of suppressor cells.

W H McBride, S E Howie.   

Abstract

Small size inocula (10(1)-10(3) cells) of cells from a syngeneic methylcholanthrene-induced fibrosarcoma (FSA) induced tolerance when injected s.c. into C3Hf mice. Mice were unable to respond to subsequent challenge with moderate, immunogenic doses of FSA. Tolerance was demonstrated in an in vivo transfer (Winn) assay and an in vitro tumour-specific TH cell assay. Low zone tolerance was associated with the presence of tumour-specific TS cells in the spleen. Moderate size inocula (10(4)-10(6) FSA cells) were immunogenic but larger cell doses (greater than 10(6)) were again tolerogenic. In the high zone, tolerance was associated with both tumour-specific TS cells and non T suppressor cells that were not tumour-specific. These results support the view that immunogenic tumours, as they grow from small cell numbers, might be able to escape host surveillance by specifically tolerizing the immune system. They also suggest that large tumour burdens can interfere with the host's immune response by inducing suppressor cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2941045      PMCID: PMC2001406          DOI: 10.1038/bjc.1986.122

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

1.  Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts.

Authors:  S Fujimoto; M I Greene; A H Sehon
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

2.  INDUCTION OF IMMUNOLOGICAL PARALYSIS IN TWO ZONES OF DOSAGE.

Authors:  N A MITCHISON
Journal:  Proc R Soc Lond B Biol Sci       Date:  1964-12-15

Review 3.  Cellular immunity against tumor antigens.

Authors:  K E Hellström; I Hellström
Journal:  Adv Cancer Res       Date:  1969       Impact factor: 6.242

4.  Immunodepression and malignancy.

Authors:  O Stutman
Journal:  Adv Cancer Res       Date:  1975       Impact factor: 6.242

5.  The effect of Corynebacterium parvum on T cell dependent tumor regression.

Authors:  W H McBride; L J Peters; K A Mason; G Barrow
Journal:  J Reticuloendothel Soc       Date:  1980-02

Review 6.  The genetic and cellular basis of regulation of the immune response to tumor antigens.

Authors:  M I Greene
Journal:  Contemp Top Immunobiol       Date:  1980

7.  Low dose tolerance preventing tumor immunity.

Authors:  E Kölsch; R Mengersen; E Diller
Journal:  Eur J Cancer       Date:  1973 Nov-Dec       Impact factor: 9.162

8.  Suppressor cell regulation of immune response to tumors: abrogation by adult thymectomy.

Authors:  C L Reinisch; S L Andrew; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

9.  Studies on the antitumor activities of pyrimidinone-interferon inducers. I. Effect against artificial and spontaneous lung metastases of murine tumors.

Authors:  L Milas; E M Hersh; D A Stringfellow; N Hunter
Journal:  J Natl Cancer Inst       Date:  1982-01       Impact factor: 13.506

10.  Correlation of "sneaking through" of tumor cells with specific immunological impairment of the host.

Authors:  R Mengersen; R Schick; E Kölsch
Journal:  Eur J Immunol       Date:  1975-08       Impact factor: 5.532

View more
  12 in total

1.  A Dynamic Model of Immune Responses to Antigen Presentation Predicts Different Regions of Tumor or Pathogen Elimination.

Authors:  Eduardo D Sontag
Journal:  Cell Syst       Date:  2017-01-26       Impact factor: 10.304

Review 2.  Radiation and inflammation.

Authors:  Dörthe Schaue; Ewa D Micewicz; Josephine A Ratikan; Michael W Xie; Genhong Cheng; William H McBride
Journal:  Semin Radiat Oncol       Date:  2015-01       Impact factor: 5.934

3.  Inhibitory effect of locally produced and exogenous interleukin-6 on tumor growth in vivo.

Authors:  G J Dougherty; J D Thacker; R S Lavey; A Belldegrun; W H McBride
Journal:  Cancer Immunol Immunother       Date:  1994-05       Impact factor: 6.968

4.  Is an immune reaction required for malignant transformation and cancer growth?

Authors:  Richmond T Prehn; Liisa M Prehn
Journal:  Cancer Immunol Immunother       Date:  2012-05-18       Impact factor: 6.968

5.  Tumor inhibitory T cell immunity may be largely a transplantation artifact not necessarily dependent upon a lack of Tregs.

Authors:  Richmond T Prehn; Liisa M Prehn
Journal:  Theor Biol Med Model       Date:  2013-06-25       Impact factor: 2.432

Review 6.  A Century of Radiation Therapy and Adaptive Immunity.

Authors:  Dörthe Schaue
Journal:  Front Immunol       Date:  2017-04-11       Impact factor: 7.561

Review 7.  A perspective on the impact of radiation therapy on the immune rheostat.

Authors:  William H McBride; Ekambaram Ganapathy; Mi-Heon Lee; Jean P Nesseler; Christine Nguyen; Dörthe Schaue
Journal:  Br J Radiol       Date:  2017-07-14       Impact factor: 3.039

8.  Thymic involution and rising disease incidence with age.

Authors:  Sam Palmer; Luca Albergante; Clare C Blackburn; T J Newman
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-05       Impact factor: 11.205

9.  Regulatory T cells in radiotherapeutic responses.

Authors:  Dörthe Schaue; Michael W Xie; Josephine A Ratikan; William H McBride
Journal:  Front Oncol       Date:  2012-08-17       Impact factor: 6.244

10.  Measurement by leukocyte adherence inhibition of autosensitization of cancer patients to myelin basic protein.

Authors:  Z Gouda; D M Thomson
Journal:  Jpn J Cancer Res       Date:  1988-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.